The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathryn Flynn, PhD
Medical College of Wisconsin
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Helen Diller Family Comprehensive Cancer Center University of California
San Francisco, California, United States
- Moffit Cancer Center
Tampa, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- the University of Chicago
Chicago, Illinois, United States
- the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- Beth Israel Deaconess Medical Center (satellite Site of Dana Farber)
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Karmanos Cancer Institute of Wayne State University
Detroit, Michigan, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Froedtert Hospital & Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2014
- Primary completion
- 6 Apr 2021
- Completion
- 6 Apr 2022
- Last update posted
- 3 Mar 2023
- Registered enrollment
- 173
- Registry id
- NCT02269267
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.